Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
100 years of glucagon and 100 more.
Wewer Albrechtsen NJ, Holst JJ, Cherrington AD, Finan B, Gluud LL, Dean ED, Campbell JE, Bloom SR, Tan TM, Knop FK, Müller TD. Wewer Albrechtsen NJ, et al. Among authors: bloom sr. Diabetologia. 2023 Aug;66(8):1378-1394. doi: 10.1007/s00125-023-05947-y. Epub 2023 Jun 27. Diabetologia. 2023. PMID: 37367959 Review.
Ghrelin for the gastroenterologist: history and potential.
Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Murray CD, et al. Among authors: bloom sr. Gastroenterology. 2003 Nov;125(5):1492-502. doi: 10.1016/j.gastro.2003.06.002. Gastroenterology. 2003. PMID: 14598266 Review.
Intra-islet glucagon signalling regulates beta-cell connectivity, first-phase insulin secretion and glucose homoeostasis.
Suba K, Patel Y, Martin-Alonso A, Hansen B, Xu X, Roberts A, Norton M, Chung P, Shrewsbury J, Kwok R, Kalogianni V, Cheng S, Liu X, Kalyviotis K, Rutter GA, Jones B, Minnion J, Owen BM, Pantazis P, Distaso W, Drucker DJ, Tan TM, Bloom SR, Murphy KG, Salem V. Suba K, et al. Among authors: bloom sr. Mol Metab. 2024 Apr 26:101947. doi: 10.1016/j.molmet.2024.101947. Online ahead of print. Mol Metab. 2024. PMID: 38677509 Free article.
Adaptive infusion of a glucagon-like peptide-1/glucagon receptor co-agonist G3215, in adults with overweight or obesity: Results from a phase 1 randomized clinical trial.
Hope DCD, Ansari S, Choudhury S, Alexiadou K, Tabbakh Y, Ilesanmi I, Lazarus K, Davies I, Jimenez-Pacheco L, Yang W, Ball LJ, Malviya R, Reglinska B, Khoo B, Minnion J, Bloom SR, Tan TM. Hope DCD, et al. Among authors: bloom sr. Diabetes Obes Metab. 2024 Apr;26(4):1479-1491. doi: 10.1111/dom.15448. Epub 2024 Jan 16. Diabetes Obes Metab. 2024. PMID: 38229453 Clinical Trial.
Commentary on "The road to reliable peptide assays is paved with good guidelines".
Kowalka AM, Alexiadou K, Cuenco J, Clarke RE, Camuzeaux S, Minnion J, Williams EL, Bech P, Purkayastha S, Ahmed AR, Takats Z, Khoo B, Whitwell HJ, Romero MG, Bloom SR, Lewis MR, Tan TM. Kowalka AM, et al. Among authors: bloom sr. Clin Endocrinol (Oxf). 2023 Jun;98(6):763-765. doi: 10.1111/cen.14894. Epub 2023 Mar 13. Clin Endocrinol (Oxf). 2023. PMID: 36915993 Free PMC article. No abstract available.
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled study.
Behary P, Alessimii H, Miras AD, Tharakan G, Alexiadou K, Aldhwayan MM, Purkayastha S, Moorthy K, Ahmed AR, Bloom SR, Tan TM. Behary P, et al. Among authors: bloom sr. Diabetes Obes Metab. 2023 Jun;25(6):1731-1739. doi: 10.1111/dom.15028. Epub 2023 Mar 13. Diabetes Obes Metab. 2023. PMID: 36811311 Clinical Trial.
Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss.
Hope DCD, Hinds CE, Lopes T, Vincent ML, Shrewsbury JV, Yu ATC, Davies I, Scott R, Jones B, Murphy KG, Minnion JS, Sardini A, Carling D, Lutz TA, Bloom SR, Tan TMM, Owen BM. Hope DCD, et al. Among authors: bloom sr. Cell Rep Med. 2022 Nov 15;3(11):100810. doi: 10.1016/j.xcrm.2022.100810. Cell Rep Med. 2022. PMID: 36384093 Free PMC article.
1,725 results